PAPER Ortiz CJ, Damasio CM, Pruccoli L, Nadur NF, de Azevedo LL, Guedes IA, Dardenne LE, Kümmerle AE, Tarozzi A, Viegas C Jr
SEARCH RESULTS
6005 RESULTS
PAPER Wang C, Zhang S, Zou Y, Ma H, Jiang D, Sheng L, Sang S, Jin L, Guan Y, Gui Y, Xu Z, Zhong C
A novel PET tracer 18F-deoxy-thiamine: synthesis, metabolic kinetics, and evaluation on cerebral thiamine metabolism status.
EJNMMI Res. 2020 Oct 20;10(1):126. PubMed: 33079296PAPER Glachet O, El Haj M
Smell your self: Olfactory stimulation improves self-concept in Alzheimer's disease.
Neuropsychol Rehabil. 2020 Oct 20;:1-17. PubMed: 33078674PAPER Vardakis JC, Chou D, Guo L, Ventikos Y
Exploring neurodegenerative disorders using a novel integrated model of cerebral transport: Initial results.
Proc Inst Mech Eng H. 2020 Nov;234(11):1223-1234. Epub 2020 Oct 20 PubMed: 33078663PAPER Borg C, Sala E, Chainay H, Labouré J, Getenet JC, Dorey JM, Laurent B, Rouch I
How do patients with Alzheimer's disease imagine their pain?
Eur J Pain. 2021 Feb;25(2):466-472. Epub 2020 Nov 7 PubMed: 33078485PAPER Rahman MA, Islam K, Rahman S, Alamin M
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease.
Mol Neurobiol. 2021 Mar;58(3):1017-1023. Epub 2020 Oct 19 PubMed: 33078369PAPER Valotassiou V, Angelidis G, Psimadas D, Tsougos I, Georgoulias P
In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer's disease imaging biomarkers?
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):969-971. Epub 2020 Oct 20 PubMed: 33078261PAPER Xing X, Li Q, Yuan M, Wei H, Xue Z, Wang T, Shi F, Shen D
DS-GCNs: Connectome Classification using Dynamic Spectral Graph Convolution Networks with Assistant Task Training.
Cereb Cortex. 2021 Jan 5;31(2):1259-1269. PubMed: 33078190PAPER Tait L, Tamagnini F, Stothart G, Barvas E, Monaldini C, Frusciante R, Volpini M, Guttmann S, Coulthard E, Brown JT, Kazanina N, Goodfellow M
EEG microstate complexity for aiding early diagnosis of Alzheimer's disease.
Sci Rep. 2020 Oct 19;10(1):17627. PubMed: 33077823PAPER Solmi M, Bodini L, Cocozza S, Seeman MV, Vieta E, Dragioti E, Carvalho AF, Fusar-Poli P
Aripiprazole monotherapy as transdiagnostic intervention for the treatment of mental disorders: An umbrella review according to TRANSD criteria.
Eur Neuropsychopharmacol. 2020 Dec;41:16-27. Epub 2020 Oct 16 PubMed: 33077324PAPER Bae JB, Lipnicki DM, Han JW, Sachdev PS, Kim TH, Kwak KP, Kim BJ, Kim SG, Kim JL, Moon SW, Park JH, Ryu SH, Youn JC, Lee DY, Lee DW, Lee SB, Lee JJ, Jhoo JH, Skoog I, Najar J, Sterner TR, Scarmeas N, Yannakoulia M, Dardiotis E, Riedel-Heller S, Roehr S, Pabst A, Ding D, Zhao Q, Liang X, Lobo A, De-la-Cámara C, Lobo E, Kim KW, for Cohort Studies of Memory in an International Consortium (COSMIC)
Parity and the risk of incident dementia: a COSMIC study.
Epidemiol Psychiatr Sci. 2020 Oct 20;29:e176. PubMed: 33077022PAPER Velayudhan L, Francis S, Dury R, Paul S, Bestwn S, Gowland P, Bhattacharyya S
Hippocampal functional connectivity in Alzheimer's disease: a resting state 7T fMRI study.
Int Psychogeriatr. 2021 Jan;33(1):95-96. Epub 2020 Oct 20 PubMed: 33076998PAPER Perez-Rando M, Dujardin S, Bennett RE, Commins C, Nibhanupudy T, Hyman BT
Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds.
Acta Neuropathol Commun. 2020 Oct 19;8(1):168. PubMed: 33076986PAPER Delrieu J, Voisin T, Saint-Aubert L, Carrie I, Cantet C, Vellas B, Payoux P, Andrieu S
The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial.
Alzheimers Res Ther. 2020 Oct 19;12(1):134. PubMed: 33076983PAPER Rubinski A, Franzmeier N, Neitzel J, Ewers M, Alzheimer’s Disease Neuroimaging Initiative (ADNI)
FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels.
Alzheimers Res Ther. 2020 Oct 19;12(1):133. PubMed: 33076977Current Filters
- Date Range : Jul 2020 to Oct 2020 x